This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit August 28, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 



SOCIETY NEWS

AST TIRN research grant request for proposals
AST
The AST Transplantation and Immunology Research Network (TIRN) research grants program supports fellows, junior faculty, and allied health professionals by funding innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2016. The request for proposals is open now at www.TIRN.org/funding. Applications must be completed by 11:59 p.m. Pacific Standard Time on Sunday, Nov. 1, 2015. For more information, visit www.TIRN.org or email TIRN@myAST.org.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Education and Clinical Tools for the ILDA: Webinar Sept. 16
AST
"Basics of Informed Consent for Living Donors" is the next webinar in the Education and Clinical Tools for the Independent Living Donor Advocate (ILDA) webinar series, and takes place Wednesday, Sept. 16 at 1 p.m. EDT. The entire nine-webinar series, developed by the AST Live Donor Community of Practice, is free to AST members and their associates: just register with an AST member username and password at www.myAST.org/ILDA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


QAPI Adverse Events: Webinar Sept. 9
AST
Join us and ASTS on Wednesday, Sept. 9, 2015 at Noon ET for the next installment of a monthly webinar series designed and presented by CMS. This webinar provides a brief look at some of the Basic Statistical Tools that may be utilized to conduct QA PI activities and a reference list of alternative tools/methods being used today. Register here
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


UPCOMING EVENTS IN TRANSPLANTATION

Surrogate Endpoints for Clinical Trials in Kidney Transplantation Public Workshop
FDA
Sept. 28, 2015 | Arlington, VA
For more information: http://www.fda.gov/Drugs/NewsEvents/ucm449248.htm

ASHI 41st Annual Meeting
ASHI
Sept. 28 - Oct. 2, 2015 | Savannah, GA
For more information: http://www.ashi-hla.org/events/annual-meeting/

2015 Banff/CST Joint Meeting
CST
Oct. 5-10, 2015 | Vancouver
For more information: http://www.cst-transplant.ca/meetings_asm.html

Society for Transplant Social Workers
STSW
Oct. 7-9, 2015 | Columbus, OH
For more information: https://www.stsw.org/conference/

ASN Kidney Week
ASN
Nov. 3-8, 2015 | San Diego, CA
For more information: https://www.asn-online.org/education/kidneyweek/

AASLD Liver Week
AASLD
Nov. 13-17, 2015 | San Francisco, CA
For more information: http://www.aasld.org/events-professional-development/liver-meeting

Call for abstracts: CEOT 2016 – Cutting Edge of Transplantation
AST
Feb. 25-27, 2016 | Phoenix, AZ
For more information: http://2016.ceot.myast.org/

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


TRANSPLANT NEWS


Fluorodeoxyglucose F18 positron emission tomography coupled with computed tomography in suspected acute renal allograft rejection
American Journal of Transplantation
Management of kidney transplant recipients (KTRs) with suspected acute rejection (AR) ultimately relies on kidney biopsy; however, noninvasive tests predicting nonrejection would help avoid unnecessary biopsy. AR involves recruitment of leukocytes avid for fluorodeoxyglucose F18 (18F-FDG), thus 18F-FDG positron emission tomography (PET) coupled with computed tomography (CT) may noninvasively distinguish nonrejection from AR.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Variation in dialysis facility referral for kidney transplantation among patients with end-stage renal disease in Georgia
Journal of the American Medical Association
Dialysis facilities in the United States are required to educate patients with end-stage renal disease about all treatment options, including kidney transplantation. Patients receiving dialysis typically require a referral for kidney transplant evaluation at a transplant center from a dialysis facility to start the transplantation process, but the proportion of patients referred for transplantation is unknown.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Circulatory support exceeding 5 years with a continuous-flow left ventricular assist device for advanced heart failure patients
Journal of Cardiothoracic Surgery
Continuous-flow left ventricular assist devices (CF-LVAD) are now providing years of safe circulatory support with enhanced quality of life. We present four cases of patients with advanced heart failure who received support for greater than 5-years with the HeartMate II CF-LVAD. One patient continues with support at 7.5 years and has decided to not undergo cardiac transplantation. Another patient has also had LVAD support for 7.7 years, initially with a pulsatile flow LVAD, and then was switched to the HeartMate II, which has continued to support him for the last 6.6 years.

Related: First clinical use of a bioprosthetic total artificial heart: Report of 2 cases

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Predonation direct and indirect costs incurred by adults who donated a kidney: Findings from the KDOC study
American Journal of Transplantation
Limited information exists on the predonation costs incurred by eventual living kidney donors (LKDs). Expenses related to completion of the donation evaluation were collected from 194 LKDs participating in the multi-center, prospective Kidney Donor Outcomes Cohort (KDOC) Study. Most LKDs (n = 187, 96 percent) reported one or more direct costs, including ground transportation (80 percent), healthcare (24 percent), lodging (17 percent) and air transportation (14 percent), totaling $101 484 (USD; mean = $523  plus or minus 942).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Missing or Broken Doppler Probes?

VTI’s disposable intraoperative Doppler probes are ready to verify technical results. There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes. Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
 


Prototheca wickerhamii algaemia: an emerging infection in solid organ transplant recipients
Transplant Infectious Disease
Prototheca wickerhamii is an alga that rarely causes human disease but has been reported increasingly among immunocompromised individuals. We report a fatal case of P. wickerhamii in a renal transplant recipient who presented with a cutaneous lesion that led to disseminated disease despite treatment with voriconazole. We reviewed previous cases of protothecosis involving solid organ transplant recipients in the literature and discussed the value of newer microbiology platforms, i.e., matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF), to achieve early diagnosis and impact outcomes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    AST Provides Comments to NIH on HOPE Act (AST)
The independent living donor advocate (AST)
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients – a 3-year serial echocardiographic substudy of the randomized controlled CENTRAL trial (Clinical Transplantation)
High emergency lung transplantation: Dramatic decrease of waiting list death rate without relevant higher post-transplant mortality (Transplant International)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Aug. 21, 2015
Aug. 14, 2015
Aug. 7, 2015
July 31, 2015



Advertisement



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063